Tower Research Capital LLC (Trc) P Lx Pharma Inc. Transaction History

Tower Research Capital LLC (Trc)

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.15 - $0.63 $7 - $31	50 New	50 $0
Q1 2022 May 12, 2022	SELL	$3.54 - $8.3 $8,117 - $19,031	-2,293 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.69 - $19.66 $17,633 - $45,080	2,293 New	2,293 $19,000
Q2 2021 Aug 16, 2021	SELL	$9.0 - $15.94 $45,108 - $79,891	-5,012 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.24 - $10.14 $23,967 - $46,380	4,574 Added 1044.29%	5,012 $45,000
Q4 2020 Feb 16, 2021	SELL	$3.01 - $6.7 $9,282 - $20,662	-3,084 Reduced 87.56%	438 $2,000
Q3 2020 Nov 16, 2020	BUY	$2.83 - $4.21 $9,327 - $13,876	3,296 Added 1458.41%	3,522 $12,000
Q2 2020 Aug 13, 2020	BUY	$2.32 - $4.02 $81 - $140	35 Added 18.32%	226 $0
Q1 2020 May 15, 2020	SELL	$1.98 - $5.87 $215 - $639	-109 Reduced 36.33%	191 $0
Q4 2019 Feb 07, 2020	BUY	$3.36 - $5.04 $1,008 - $1,512	300 New	300 $1,000
Q2 2018 Aug 15, 2018	SELL	$3.3 - $4.5 $2,178 - $2,970	-660 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$3.2 - $7.43 $2,112 - $4,903	660 New	660 $2,000
Q4 2017 Feb 09, 2018	SELL	$6.3 - $9.1 $4,699 - $6,788	-746 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$6.08 - $7.0 $4,535 - $5,222	746	746 $5,000

62.7K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.